Abstract:
Provided herein are compounds of the formula (I), as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity, type II diabetes mellitus and metabolic syndrome.
Abstract:
The present invention relates to modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Regulator ("CFTR"), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
Abstract:
The present invention relates to modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including CF Transmembrane Regulator ("CFTR"), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
Abstract:
It is an object of the present invention to provide novel signs and visual displays produced by different behavior of liquids applied to hydrophilic and hydrophobic surfaces on patterned surfaces. It is also an object of the present invention to provide articles baring logos and alphanumeric text produced by application of liquids to patterned material surfaces. There is further provided a method for producing novel signs and visual displays by producing patterned hydrophobic and hydrophilic surfaces. Also provided are processes for producing patterned surfaces.